Kiyuk Chang - Concepedia

Author

Kiyuk Chang

Also Known As

Byeong‐Keuk Kim, Chang, K., Doo-Il Kim, Ho-Joong Youn, K Y Chang, K. Chang, K. Y. Chang, K.Y. Chang, KIYUK CHANG, Ki-Yuk Chang

401

Publications

9.3K

Citations

H-Index

127

Concepts

All Affiliations

Catholic University of Korea The Catholic University of Korea Seoul St. Mary's Hospital The Catholic University of Korea Uijeongbu St. Mary's Hospital Chonnam National University Hospital The Catholic University of Korea Incheon St. Mary's Hospital

About

Kiyuk Chang is an author at Catholic University of Korea specializing in medicine, cardiovascular disease, and coronary heart disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	50	5.6K
2	Public Health	17	24	3.9K
3	Health Sciences	8	8	392
4	Engineering	5	5	175
5	Allergy	1	1	15

Kiyuk Chang

123

Publications

7.7K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial Seung‐Jung Park, Jung‐Min Ahn, Do‐Yoon Kang, The Lancet Percutaneous Coronary InterventionOptimal Medical TherapyCardiovascular DiseaseHealth PolicyPreventive Cardiology	2024	212
Infarcted Myocardium-Primed Dendritic Cells Improve Remodeling and Cardiac Function After Myocardial Infarction by Modulating the Regulatory T Cell and Macrophage Polarization Eun Ho Choo, Jun‐Ho Lee, Eunhye Park, Circulation	2017	178
Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial Chan Joon Kim, Mahn‐Won Park, Min Chul Kim, The Lancet Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineRandomised Trial	2021	177
Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2hi macrophages in infarcted hearts Seung‐Hyun Jung, Byung‐Hee Hwang, Sun Shin, Nature Communications	2022	170
The stress hyperglycemia ratio, an index of relative hyperglycemia, as a predictor of clinical outcomes after percutaneous coronary intervention Yeoree Yang, Tae‐Hoon Kim, Kun‐Ho Yoon, International Journal of Cardiology Metabolic SyndromePercutaneous Coronary InterventionDiabetes ManagementHealth PolicyCardiovascular Disease	2017	162
Prognosis and Predictors of Mortality in Patients Suffering Myocardial Infarction With Non‐Obstructive Coronary Arteries Eun Ho Choo, Kiyuk Chang, Kwan Yong Lee, Journal of the American Heart Association Coronary Artery DiseaseAcute Myocardial InfarctionNon‐obstructive Coronary ArteriesPublic HealthAtherosclerosis	2019	151
Assessment and diagnostic relevance of novel serum biomarkers for early decision of ST-elevation myocardial infarction Hun‐Jun Park, Ji Heon Noh, Jung Woo Eun, Oncotarget	2015	132
Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients Joshua P. Lewis, Joshua Backman, Jean‐Luc Reny, European Heart Journal - Cardiovascular Pharmacotherapy	2019	98

Page 1